Medicine and Dentistry
Patient
100%
Adult
92%
Malaria Falciparum
76%
Refugee
67%
Malaria
64%
Woman
54%
Pregnancy
40%
Therapeutic Procedure
23%
Labor
22%
Childbirth
21%
Adolescent
20%
Observational Study
20%
Inpatient
20%
Platelet
18%
Experience
18%
Renal Replacement Therapy
18%
Analysis
18%
Odds Ratio
15%
Infant
15%
Feeding
15%
Pulmonary Edema
14%
Laboratory
14%
Assessment
14%
Acute Kidney Injury
13%
Obstruction
13%
Hospital
12%
Disease
12%
Infant Feeding
12%
Fluid Resuscitation
12%
Lactic Acid
12%
Retrospective Cohort Study
11%
Symptoms
11%
Mortality
10%
Overnutrition
10%
Prognosis
10%
Kidney Function
10%
Thrombocytopenia
10%
Cell Adhesion
10%
COVID-19 Vaccine
9%
Gestational Age
9%
Hemoglobin
9%
Prospective Cohort Study
9%
Dengue Hemorrhagic Fever
9%
Cardiovascular System
9%
Sputum Smear
9%
Neonatal Infant
9%
Liver
9%
Helminthiasis
9%
Needs Assessment
9%
Intrapartum Care
9%
Immunology and Microbiology
Plasmodium falciparum
62%
Blood Plasma
40%
Kidney
27%
Plasmodium vivax
24%
Erythrocyte
23%
Hemocyte
19%
Dengue Fever
18%
Hemorrhagic Fever
18%
Rosette Formation
18%
Levamisole
18%
Parasite
17%
Time
17%
Sample
16%
Cell Adhesion
15%
Parasitemia
15%
Oxidative Stress
12%
Monospecific Antibody
11%
Parasite Load
11%
Enzyme-Linked Immunosorbent Assay
9%
Immunodiagnostics
9%
Drug Resistance
9%
Haplotype
9%
Prevalence
9%
Human Rotavirus
9%
Rotavirus
9%
Extract
9%
Viral Disease
9%
Chikungunya Virus
9%
Human
9%
Platelet
9%
Cytokine
9%
Larva
9%
Hepatitis
9%
Chloroquine
9%
Merozoite
9%
Liquid
9%
Spectrum
9%
Acid Base Balance
9%
Interleukin 8
9%
Gene
7%
Venous Blood
7%
Allele
7%
Mutant
7%
Viral Load
6%
Antigen
5%
Excretion
5%
Microcirculation
5%
Trophozoite
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glucose 6 Phosphate Dehydrogenase
18%
Acid
18%
Replacement Therapy
18%
Infection
17%
Artesunate
16%
Hemoglobin
15%
Pathogenesis
14%
Anemia
12%
Clinical Trial
12%
Efficacy Study
12%
Hemolysis
12%
Creatinine
12%
Lung Edema
11%
Diseases
11%
Acute Kidney Failure
10%
Paracetamol
9%
Influenza
9%
Dengue
9%
Plasmodium falciparum
9%
Reinfection
9%
Observational Study
9%
Relenza
9%
Oseltamivir
9%
Blindness
9%
Helminthiasis
9%
Open-Label Trial
9%
Chikungunya
9%
Controlled Clinical Trial
9%
Benflumetol
9%
Drug Screening
9%
Prognosis
9%
Von Willebrand Factor
8%
Convalescence
5%
Hepatitis
5%
Quinine
5%
8 Aminoquinoline Derivative
5%